GENE ONLINE|News &
Opinion
Blog

NSCLC
EGFR
Weekly in Asia | SEP-1
2019-09-17
Trials & Approvals Personalized Medicine
Rozlytrek Becomes the Third Tumor-Agnostic Medicine to be Approved by the USFDA
2019-08-21
Asia-Pacific
Weekly in Asia 20190602-0608
2019-06-11
Trials & Approvals EGFR
Vizimpro bags EU approval for NSCLC treatment
2019-04-16
Trials & Approvals Antibody
Tecentriq bags yet another FDA approval, this time as a combo therapy for NSCLC
2018-12-24
R&D
A new player emerges in the non-small cell lung cancer (NSCLC) therapy scene
2018-10-11
Trials & Approvals Anti-PD-1
Innovent reports clinical trial results of its anti-PD-1 monoclonal antibody
2018-09-26
Technology Lung Cancer
Fighting Lung Cancer with Precision Warfare
2018-06-21
1 2 3 4
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top